BrainStorm Cell Therapeutics
BCLI
#10391
Rank
S$7.85 M
Marketcap
S$0.71
Share price
-11.11%
Change (1 day)
-71.56%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2025 (TTM): -S$14.3 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$14.77 Million, an increase over its 2023 earnings that were of -S$21.85 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$14.3 Million-3.22%
2024 -S$14.77 Million-32.39%
2023 -S$21.85 Million-29.18%
2022 -S$30.85 Million-0.74%
2021 -S$31.08 Million-23.12%
2020 -S$40.43 Million36.8%
2019 -S$29.55 Million66.71%
2018 -S$17.73 Million181.66%
2017 -S$6.3 Million-0.6%
2016 -S$6.34 Million-41.31%
2015 -S$10.79 Million-8.22%
2014 -S$11.76 Million89.74%
2013 -S$6.2 Million42.27%
2012 -S$4.36 Million-12.45%
2011 -S$4.98 Million63.04%
2010 -S$3.05 Million35.52%
2009 -S$2.26 Million-48.99%
2008 -S$4.42 Million-44.39%
2007 -S$7.94 Million
2005 -S$4.11 Million-91.44%
2004 -S$48.01 Million94007.62%
2003 -S$0.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Biogen
BIIB
S$2.41 B-17,654.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$12.56 B-91,248.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-S$1.01 Billion 7,189.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-S$0.96 Billion 6,832.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
S$26.25 M-290.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-S$0.33 Billion 2,255.61%๐Ÿ‡บ๐Ÿ‡ธ USA